Early Phase 1 Asthma Trial, Recruiting (NCT06137040)

Early Phase 1 Asthma Trial, Recruiting NCT06137040 Sponsor: University of Oklahoma Condition: Asthma

Printed from Voxsanity (voxsanity.com.au) — NCT06137040 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Asthma

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

The child is between 5 and 17 years old
The child has come to the Emergency Department with a breathing problem that has been rated as "moderate" severity
The child's parent(s) or caregiver(s) speak English

Who may not be able to join:

The child has a long-term medical condition such as a chronic lung disease (other than asthma), cerebral palsy, a heart condition they were born with, dependence on a breathing tube in the throat (tracheostomy), or a muscle weakness condition called myasthenia gravis
The child is pregnant
The child's parent(s) or caregiver(s) do not speak English

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 28 July 2026

Early Phase 1 studies are small, early exploratory studies that come before the main Phase 1 to 3 testing, so a standard phase success rate does not apply.

Contact this trial

Principal Investigator: Ryan McKee, MD, University of Oklahoma

Phone: 4056308997

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT06137040

Sponsor: University of Oklahoma

Phase: Early Phase 1

Status: Recruiting

Condition: Asthma

Trial contact: 4056308997

More information: https://clinicaltrials.gov/study/NCT06137040

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

The child is between 5 and 17 years old
The child has come to the Emergency Department with a breathing problem that has been rated as "moderate" severity
The child's parent(s) or caregiver(s) speak English

Who may not be able to join:

The child has a long-term medical condition such as a chronic lung disease (other than asthma), cerebral palsy, a heart condition they were born with, dependence on a breathing tube in the throat (tracheostomy), or a muscle weakness condition called myasthenia gravis
The child is pregnant
The child's parent(s) or caregiver(s) do not speak English

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 28 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Early Phase 1

Sponsor

University of Oklahoma

Registry

ClinicalTrials.gov

Start date

30 November 2023

Est. completion

31 May 2025

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Change in Length of Stay in Patients who receive IV Magnesium within the first hour (experimental group) vs control group

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov